DANA DEMMITT: Open Payments
NPI 1710442710 · FRANKLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 56 payments from 5 companies in 2025. Trend: 2023 $741 · 2024 $1,120 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $424 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $88 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Astellas Pharma US Inc | 1 | $29 |
| Lilly USA, LLC | 1 | $19 |
Products named: QULIPTA, VRAYLAR, UBRELVY, CAPLYTA, CREON, Veozah, MOUNJARO, BREZTRI.
Industry payments across OH — which companies pay providers there.
